# DBS Evaluation of Fujirebio INNOTEST® HCV Ab IV

> **NCT04317729** · NA · COMPLETED · sponsor: **Foundation for Innovative New Diagnostics, Switzerland** · enrollment: 300 (actual)

## Conditions studied

- Hepatitis C Virus Infection

## Interventions

- **DEVICE:** Fujirebio INNOTEST® HCV Ab IV assay

## Key facts

- **NCT ID:** NCT04317729
- **Lead sponsor:** Foundation for Innovative New Diagnostics, Switzerland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-30
- **Primary completion:** 2020-04-30
- **Final completion:** 2020-05-31
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2020-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04317729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04317729, "DBS Evaluation of Fujirebio INNOTEST® HCV Ab IV". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04317729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*